APA (7th ed.) Citation

AG, S., JR, S., A, A., CS, C., P, C., M, C., . . . A, S. (2023). Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial. JAMA neurology, 80(12), 1334. https://doi.org/10.1001/jamaneurol.2023.3711

Chicago Style (17th ed.) Citation

AG, Smith, et al. "Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial." JAMA Neurology 80, no. 12 (2023): 1334. https://doi.org/10.1001/jamaneurol.2023.3711.

MLA (9th ed.) Citation

AG, Smith, et al. "Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial." JAMA Neurology, vol. 80, no. 12, 2023, p. 1334, https://doi.org/10.1001/jamaneurol.2023.3711.